Project: Next generation drug delivery and manufacturing modeling
| Acronym | NextGen DDaMM (Reference Number: 113382) |
| Duration | 01/10/2019 - 02/10/2021 |
| Project Topic | The project will reduce drug development time and risk and increase drug manufacturing efficiency by accurately modeling drug properties. PSE offers market-leading drug modeling software. The challenges we seek to address are modeling properties of: - Small molecule drugs (SMDs) – with game-changing accuracy - Biological therapeutics (BTs) – as the first commercial tool The objective is to develop and test pioneering methods with Hafnium Labs (HL) and DTU to expand PSE's offering. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 11 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Process Systems Enterprise Limited | Coordinator | United Kingdom |
| 2 | Hafnium Labs Q-props ApS | Partner | Denmark |
| 3 | Danmarks Tekniske Universitet | Partner | Denmark |